Why the study?
Does an elevated triglyceride-glucose (TyG) index predict all-cause and cardiac mortality in patients with coronary heart disease undergoing PCI?
Population
2,533 patients with coronary heart disease who underwent percutaneous coronary intervention, using data from…
Comparison
Elevated triglyceride-glucose (TyG) index vs Lower triglyceride-glucose (TyG) index
Design
Cohort
Key result
An elevated Triglyceride-glucose (TyG) index was independently associated with an increased risk of all-cause mortality (OR 1.7) and cardiac mortality in patients with coronary heart disease undergoing percutaneous coronary intervention.
Authors
Loading...
TyG index may aid post-PCI mortality risk stratification; leaves open need for prospective validation before clinical adoption.
Cohort (n=2,533)
No
Does an elevated triglyceride-glucose (TyG) index predict all-cause and cardiac mortality in patients with coronary heart disease undergoing PCI?
Odds Ratio: 1.7 (95% CI 1.1–2.7)
p-value: p=0.030
An elevated triglyceride-glucose index is independently associated with an increased risk of all-cause and cardiac mortality in patients with coronary heart disease following PCI.
Wan et al. (2026) conducted a cohort in Coronary heart disease (CHD) following percutaneous coronary intervention (PCI) (n=2,533). Elevated Triglyceride-glucose (TyG) index vs. Lower Triglyceride-glucose (TyG) index was evaluated on All-cause death (OR 1.7, 95% CI 1.1-2.7, p=0.030). An elevated Triglyceride-glucose (TyG) index was independently associated with an increased risk of all-cause mortality (OR 1.7) and cardiac mortality in patients with coronary heart disease undergoing percutaneous coronary intervention.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: